Viracept (State of Florida DOH Central Pharmacy)


Welcome to the PulseAid listing for the Viracept drug offered from State of Florida DOH Central Pharmacy. This HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: State of Florida DOH Central Pharmacy
NON-PROPRIETARY NAME: NELFINAVIR MESYLATE
SUBSTANCE NAME: NELFINAVIR MESYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA]
ROUTE: ORAL
DOSAGE FORM: TABLET, FILM COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00


Viracept HUMAN PRESCRIPTION DRUG Details:

Item DescriptionViracept from State of Florida DOH Central Pharmacy
LABELER NAME: State of Florida DOH Central Pharmacy
DEA SCHEDULE:
ACTIVE STRENGTH: 625(mg/1)
START MARKETING DATE: 2009-07-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53808-0809_d93799ad-308b-4f54-b8d5-07402cd8882e
PRODUCT NDC: 53808-0809
APPLICATION NUMBER: NDA021503

Other NELFINAVIR MESYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AGOURONVIRACEPT
H.J. Harkins Company, Inc.VIRACEPT
PD-Rx Pharmaceuticals, Inc.VIRACEPT
State of Florida DOH Central PharmacyViracept